| |
| |
|
| Insider
Information: |
Gelone Steven P. |
| Relationship: |
Director |
| City: |
King Of Prussia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,283 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,625 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,283 |
|
|
| Total
Value |
$5,625 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nabriva Therapeutics AG |
NBRV |
Director |
2023-01-29 |
14,283 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Chief Development OfficerOffic |
• – – |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,274 |
|
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-09-30 |
4 |
D |
$2.08 |
$6 |
D/D |
(3) |
14,449 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-10-31 |
4 |
D |
$2.54 |
$8 |
D/D |
(3) |
14,442 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-11-30 |
4 |
D |
$2.25 |
$7 |
D/D |
(3) |
14,435 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-12-31 |
4 |
D |
$1.89 |
$6 |
D/D |
(3) |
14,428 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-10-06 |
4 |
D |
$2.72 |
$11 |
D/D |
(4) |
14,445 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-11-06 |
4 |
D |
$2.24 |
$9 |
D/D |
(4) |
14,438 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-12-06 |
4 |
D |
$2.02 |
$8 |
D/D |
(4) |
14,431 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2023-01-06 |
4 |
D |
$1.30 |
$7 |
D/D |
(5) |
14,423 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-02-28 |
4 |
D |
$0.45 |
$27 |
D/D |
(61) |
362,300 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-03-31 |
4 |
D |
$0.42 |
$26 |
D/D |
(61) |
362,150 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-04-30 |
4 |
D |
$0.31 |
$19 |
D/D |
(61) |
362,000 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-05-31 |
4 |
D |
$0.21 |
$13 |
D/D |
(61) |
361,850 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-06-30 |
4 |
D |
$0.18 |
$11 |
D/D |
(61) |
361,700 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-07-31 |
4 |
D |
$0.18 |
$11 |
D/D |
(61) |
361,550 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-08-31 |
4 |
D |
$0.16 |
$10 |
D/D |
(61) |
361,400 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-12-31 |
4 |
D |
$2.42 |
$152 |
D/D |
(63) |
35,729 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2021-02-28 |
4 |
D |
$2.39 |
$151 |
D/D |
(63) |
78,091 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-03-31 |
4 |
D |
$1.66 |
$105 |
D/D |
(63) |
78,028 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-04-30 |
4 |
D |
$1.78 |
$112 |
D/D |
(63) |
367,374 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-05-31 |
4 |
D |
$1.38 |
$87 |
D/D |
(63) |
367,219 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-06-30 |
4 |
D |
$1.35 |
$85 |
D/D |
(63) |
367,064 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-07-31 |
4 |
D |
$1.10 |
$69 |
D/D |
(63) |
366,909 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-08-31 |
4 |
D |
$1.06 |
$67 |
D/D |
(63) |
366,754 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-09-30 |
4 |
D |
$1.19 |
$75 |
D/D |
(63) |
366,598 |
0 |
- |
|
71 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
